NMC Health plc
NMMCF · OTC
6/30/2019 | 12/31/2018 | 6/30/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | – | $1 | $1 | $1 |
| % Growth | – | 0% | 28.3% | – |
| Cost of Goods Sold | – | $1 | $1 | $0 |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | 40.9% | 40.9% | 39.6% |
| R&D Expenses | – | $0 | $0 | $0 |
| G&A Expenses | – | $0 | $0 | $0 |
| SG&A Expenses | – | $0 | $0 | $0 |
| Sales & Mktg Exp. | – | $0 | $0 | $0 |
| Other Operating Expenses | – | $0 | $0 | $0 |
| Operating Expenses | – | $0 | $0 | $0 |
| Operating Income | – | $0 | $0 | $0 |
| % Margin | – | 18.5% | 18.5% | 17.1% |
| Other Income/Exp. Net | – | -$0 | -$0 | -$0 |
| Pre-Tax Income | – | $0 | $0 | $0 |
| Tax Expense | – | $0 | $0 | $0 |
| Net Income | – | $0 | $0 | $0 |
| % Margin | – | 12.1% | 12.1% | 11.6% |
| EPS | – | 0.6 | 0.6 | 0.46 |
| % Growth | – | 0% | 30.4% | – |
| EPS Diluted | – | 0.6 | 0.6 | 0.45 |
| Weighted Avg Shares Out | – | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | – | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $0 | $0 | $0 |
| EBITDA | – | $0 | $0 | $0 |
| % Margin | – | 22.8% | 22.8% | 20.9% |